Share chart Adhera Therapeutics Inc
Extended chart
Simple chart
About Adhera Therapeutics Inc
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.ISIN | US00687E1091 |
---|---|
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://adherathera.com |
Цена ао | 0.0001 |
Change price per day: | 0% (0.0001) |
---|---|
Change price per week: | 0% (0.0001) |
Change price per month: | 0% (0.0001) |
Change price per 3 month: | 0% (0.0001) |
Change price per half year: | -95.83% (0.0024) |
Change price per year: | -99% (0.01) |
Change price per 3 year: | -99.88% (0.08) |
Change price per 5 year: | -99.85% (0.065) |
Change price per year to date: | -50% (0.0002) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Andrew Albert Kucharchuk M.B.A. | Vice Chairman, COO, Acting CFO & Chief Business Officer | 1981 (44 years) |
Address: United States, Baton Rouge, 8000 Innovation Parkway - open in Google maps, open in Yandex maps
Website: https://adherathera.com
Website: https://adherathera.com